Renasant Bank’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$250K Sell
401
-40
-9% -$23.4K 0.17% 120
2026
Q2
$234K Buy
441
+13
+3% +$6K 0.15% 127
2026
Q1
$206K Hold
428
– – 0.15% 135
2025
Q4
$240K Sell
428
-19
-4% -$10.8K 0.16% 126
2025
Q3
$230K Buy
+447
New +$195K 0.15% 134

Other funds holding MEDP

Renasant Bank's MEDP Position: Q3 2026 in Review

Renasant Bank reduced its Medpace (MEDP) stake by 9.1% in Q3 2026, selling an estimated $23.4K and leaving 401 shares worth $250K. The position accounts for 0.17% of the portfolio, ranked #120.

Renasant Bank first reported a position in MEDP in Q3 2025 and has held it in 5 quarters since. 759 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Renasant Bank held 401 shares of Medpace worth $250K as of Q3 2026.
  • Renasant Bank sold 40 Medpace shares in Q3 2026, an estimated $23.4K.
  • Medpace made up 0.17% of Renasant Bank's portfolio in Q3 2026, its #120 holding.
  • Renasant Bank first reported a position in Medpace in Q3 2025 and has held it in 5 quarters since.
  • 759 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Renasant Bank's 13F filing for Q3 2026, filed 5 Nov 2026.